| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2288 | Citalopram hydrobromide, CTP Process | HETERO DRUGS LIMITED Hyderabad IN | 100008415;100014434 | CEP 2012-120 - Rev 05 | 2025/08/01 | Valid | Chemical | 2025/08/01 | Minor revision|CEP granted|01/08/2025; Minor revision|CEP granted|11/09/2024; Minor revision|CEP granted|17/11/2021 |
||
| 2760 | Brimonidine tartrate | SIEGFRIED GRAFTON, INC. Grafton US | 100042515;100070251 | CEP 2015-265 - Rev 01 | 2025/08/01 | Valid | Chemical | 2025/08/01 | Notification|CEP granted|01/08/2025; Notification|Accepted - CEP remains valid|02/05/2024; Notification|Accepted - CEP remains valid|04/05/2023; Renewal|CEP granted|24/01/2023; Notification|CEP granted|27/08/2021 |
||
| 2675 | Irinotecan hydrochloride trihydrate | LAURUS LABS LIMITED Hyderabad IN | 100011702;100032608 | CEP 2019-292 - Rev 03 | 2025/08/01 | Valid | 19/10/2026 | Chemical | 2025/08/01 | Minor revision|CEP granted|01/08/2025; Minor revision|Rejected|23/05/2025; Minor revision|Accepted - CEP remains valid|25/11/2024; Minor revision|CEP granted|11/12/2023; Minor revision|CEP granted|26/01/2023 |
|
| 2258 | Olanzapine | SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai IN | 100032307;100078783 | CEP 2012-050 - Rev 04 | 2025/07/31 | Valid | Chemical | 2025/07/31 | Notification|CEP granted|31/07/2025; Major revision|CEP granted|14/05/2025; Minor revision|CEP granted|21/02/2023 |
||
| 1295 | Calcifediol monohydrate | FORMOSA LABORATORIES, INC. Taoyuan TW | 100011879;100018688 | CEP 2019-163 - Rev 03 | 2025/07/31 | Valid | 28/10/2026 | Chemical | 2025/07/31 | Minor revision|CEP granted|31/07/2025; Minor revision|CEP granted|27/08/2024; Notification|Rejected|08/07/2024; Administrative procedure|CEP granted|16/11/2021 |
|
| 2593 | Docetaxel | FUJIAN SOUTH PHARMACEUTICAL CO., LTD. Sanming CN | 100012371;100021536 | CEP 2016-204 - Rev 05 | 2025/07/31 | Valid | Chemical | 2025/07/31 | Minor revision|CEP granted|31/07/2025; Renewal|CEP granted|20/12/2023; Minor revision|CEP granted|03/10/2022; Minor revision|CEP granted|16/03/2021 |
||
| 1781 | Fludarabine phosphate | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2005-257 - Rev 06 | 2025/07/31 | Valid | Chemical | 2025/07/31 | Minor revision|CEP granted|31/07/2025; Minor revision|CEP granted|09/04/2024; Notification|Accepted - CEP remains valid|09/09/2022; Notification|CEP granted|10/11/2021; Notification|Accepted - CEP remains valid|25/03/2021 |
||
| 2631 | Rosuvastatin calcium | CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN | 100038839;100060978 | CEP 2022-009 - Rev 02 | 2025/07/31 | Valid | 01/06/2028 | Chemical | 2025/07/31 | Minor revision|CEP granted|31/07/2025; Minor revision|CEP granted|14/05/2024; Notification|Rejected|22/03/2024; New application|CEP granted|01/06/2023 |
|
| 2338 | Mirtazapine | MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN | 100011550;100021133 | CEP 2024-116 - Rev 00 | 2025/07/31 | Valid | 31/07/2030 | Chemical | 2025/07/31 | New application|CEP granted|31/07/2025 | |
| 1076 | Bumetanide | MEDILUX LABORATORIES PRIVATE LIMITED Pithampur IN | 100023732;100032901 | CEP 2024-248 - Rev 00 | 2025/07/31 | Valid | 31/07/2030 | Chemical | 2025/07/31 | New application|CEP granted|31/07/2025 | |
| 3139 | Brivaracetam | ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City CN | 100012174;100018701 | CEP 2025-089 - Rev 00 | 2025/07/31 | Valid | 31/07/2030 | Chemical | 2025/07/31 | New application|CEP granted|31/07/2025 | |
| 2541 | Quetiapine Fumarate, ID 3871 | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2020-234 - Rev 03 | 2025/07/31 | Valid | Chemical | 2025/07/31 | Renewal|CEP granted|31/07/2025; Minor revision|CEP granted|19/12/2023; Notification|CEP granted|22/02/2022; New application|CEP granted|13/11/2020 |
||
| 1524 | Gliclazide | BAL PHARMA LIMITED Bengaluru IN | 100016398;100041736 | CEP 2001-273 - Rev 08 | 2025/07/30 | Valid | Chemical | 2025/07/30 | Administrative procedure|CEP granted|30/07/2025; Notification|CEP granted|19/06/2025; Notification|CEP granted|21/03/2025; Notification|CEP granted|23/10/2023; Minor revision|CEP granted|17/04/2023 |
||
| 2015 | Ebastine | BAL PHARMA LIMITED Bengaluru IN | 100016398;100041736 | CEP 2013-051 - Rev 04 | 2025/07/30 | Valid | Chemical | 2025/07/30 | Administrative procedure|CEP granted|30/07/2025; Notification|CEP granted|19/06/2025; Notification|CEP granted|22/04/2024; Minor revision|CEP granted|28/11/2022 |
||
| 333 | Heparin sodium | HELM PORTUGAL UNIPESSOAL LDA. Carnaxide PT | 100004498;100075893 | CEP 2002-012 - Rev 08 | 2025/07/30 | Valid | Chemical | 2025/07/30 | Notification|CEP granted|30/07/2025; Major revision|CEP granted|27/11/2024; Monograph revision|Accepted - CEP remains valid|19/06/2024; Major revision|CEP granted|09/10/2020 |
||
| 1524 | Gliclazide, AP | BAL PHARMA LIMITED Bengaluru IN | 100016398;100041736 | CEP 2013-039 - Rev 04 | 2025/07/30 | Valid | Chemical | 2025/07/30 | Administrative procedure|CEP granted|30/07/2025; Notification|CEP granted|23/06/2025; Administrative procedure|CEP granted|03/03/2025; Minor revision|CEP granted|13/02/2025; Renewal|CEP granted|27/08/2020 |
||
| 267 | Caffeine | HEBEI GUANGXIANG PHARMACEUTICAL CO. LTD. Cangzhou CN | 100048186;100079867 | CEP 2024-083 - Rev 01 | 2025/07/30 | Valid | 17/06/2030 | Chemical | 2025/07/30 | Administrative procedure|CEP granted|30/07/2025; New application|CEP granted|17/06/2025 |
|
| 1093 | Cyclopentolate hydrochloride | ESTEVE QUIMICA S.A. Barcelona ES | 100002266;100056508 | CEP 2016-078 - Rev 01 | 2025/07/30 | Valid | Chemical | 2025/07/30 | Minor revision|CEP granted|30/07/2025; Minor revision|Accepted - CEP remains valid|11/01/2024; Renewal|CEP granted|19/10/2022; Transfer of holdership|CEP granted|16/03/2022; Administrative procedure|CEP granted|22/07/2020 |
||
| 845 | Mebendazole, Form-C, micronised and non-micronised | MSN LIFE SCIENCES PRIVATE LIMITED Medak IN | 100018316;100027671 | CEP 2018-242 - Rev 02 | 2025/07/30 | Valid | Chemical | 2025/07/30 | Renewal|CEP granted|30/07/2025; Minor revision|CEP granted|19/08/2022 |
||
| 1425 | Fosfomycin trometamol | NORTHEAST PHARMACEUTICAL GROUP CO. LTD Shenyang CN | 100021339;100054155 | CEP 2023-201 - Rev 01 | 2025/07/30 | Valid | 20/05/2030 | Chemical | 2025/07/30 | Notification|CEP granted|30/07/2025; New application|CEP granted|20/05/2025 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号